Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. ODX.L Share Price
  4. ODX.L Share Regulatory News
  5. Statement re Media Comment

Pin to quick picksODX.L Regulatory News (ODX)

ODX.L Information
  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Media Comment

8 Feb 2021 07:00

RNS Number : 2330O
Omega Diagnostics Group PLC
08 February 2021
 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Statement re. media comment

 

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the article published online yesterday by the Financial Times.

 

The Company can confirm that it is continuing to modify its Alva-based facility to upscale significantly its lateral flow test production capacity. When contracts or supply agreements are signed to utilise this capacity the Company will announce this in line with AIM disclosure obligations.

 

Contacts: 

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Bill Rhodes, Interim Non-Executive Chairman

Colin King, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

 

 

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/Edward Whiley (Corporate Finance)

 

Alice Lane (ECM)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCBUGDDRBGDGBR
12345678910
Date   Source Headline
12th Nov 202010:04 amRNSResponse to media comment
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
11th Nov 20207:00 amRNSInvestor Presentation - Q&A update
10th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:01 amRNSPrice Monitoring Extension
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 202010:45 amRNSExercise of Options and Total Voting Rights
6th Nov 20209:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20207:00 amRNSChinese approval for Food Detective® test
30th Oct 20203:00 pmRNSExercise of Options and Total Voting Rights
29th Oct 20206:07 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSTrading update and notice of interim results
20th Oct 202011:00 amRNSExercise of Options and Total Voting Rights
20th Oct 20207:00 amRNSNotice of Trading Update and Investor Presentation
19th Oct 20207:00 amRNSUK-RTC contract for the Supply of Goods
14th Oct 20207:45 amRNSExercise of Options and Total Voting Rights
9th Oct 20204:15 pmRNSExercise of Options and Total Voting Rights
7th Oct 20207:00 amRNSUK Government contract for UK-RTC
6th Oct 20205:45 pmRNSHolding(s) in Company
6th Oct 20204:46 pmRNSUK Government contract for UK-RTC
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
2nd Oct 202012:00 pmRNSPreliminary report published by Ulster University
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSInvestor Presentation
24th Sep 20202:05 pmRNSSecond Price Monitoring Extn
24th Sep 20202:00 pmRNSPrice Monitoring Extension
15th Sep 20205:51 pmRNSExercise of Options and Total Voting Rights
15th Sep 20209:45 amRNSHolding(s) in Company
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20202:05 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
10th Sep 202010:11 amRNSHolding(s) in Company
7th Sep 20202:33 pmRNSStmnt re Share Price Movement
7th Sep 20207:00 amRNSCompletion of AbC-19 self-test usability study
3rd Sep 20207:00 amRNSCE-Mark for Mologic COVID-19 antibody test
1st Sep 20204:07 pmRNSExercise of Options and Total Voting Rights
28th Aug 20209:45 amRNSHolding(s) in Company
26th Aug 202011:20 amRNSResult of AGM
26th Aug 20207:00 amRNSExercise of Options and Total Voting Rights
24th Aug 20209:30 amRNSExercise of Options and Total Voting Rights
21st Aug 20207:00 amRNSWHO Prequalification received
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.